Sign in to continue:

Monday, March 23rd, 2026

Xtrackers Annual General Meeting 2026 Notice: Dividend Allocation, Director Elections, and Voting Procedures

Xtrackers Annual General Meeting 2026: Key Financial Highlights & Corporate Actions

Xtrackers, a Luxembourg-based investment company, has announced its Annual General Meeting (AGM) for shareholders, scheduled for 24 April 2026. The notice details the agenda, board and auditor reports, proposed director remuneration, and shareholder voting procedures. Below is an analysis of the available financial and corporate information, structured for investors seeking insight into the company’s latest performance and governance actions.

Key Financial Metrics and Earnings Summary

The AGM agenda confirms the approval of audited financial statements for the year ending 31 December 2025, including allocation of net results. Interim dividends were paid during the financial year, with remaining net results carried forward. The interim dividend payments are detailed in the Notes to the Financial Statements section of the Annual Report. However, specific figures for revenue, earnings, or EPS are not provided in the notice.

Metric FY 2025 FY 2024 Interim Dividends (2025) YoY Change
Audited Net Results Carried Forward (post interim) N/A Details in Annual Report N/A
Dividend Payments Interim paid, remainder carried forward N/A See Notes N/A

Director Remuneration

The AGM proposes remuneration for independent and external directors:

  • Alfred Francois Brausch (Chairman): €30,000 per annum
  • Thilo Wendenburg: €25,000 per annum
  • Stefan Kreuzkamp: €12,500 per annum

Non-independent directors receive no remuneration. Payments are pro rata for the period ending on the AGM date and are based on the number of Sub-Funds at year-end.

Board and Auditor Actions

  • Re-election of Directors: Four directors (Philippe Ah-Sun, Alfred Francois Brausch, Thilo Wendenburg, Stefan Kreuzkamp, Simon Klein) are up for re-election until the next AGM for FY 2026.
  • KPMG Audit S.à r.l.: Proposed for re-election as statutory auditor for another year.
  • Board Discharge: Discharge of the Board for performance during FY 2025 is proposed.

Dividend and Earnings Actions

Interim dividend payments were made during FY 2025, with remaining net results carried forward. No specific comparative figures or payout ratios are provided, but the treatment indicates a conservative approach to profit allocation.

Corporate Actions and Shareholder Voting Arrangements

  • Voting: No quorum required; resolutions pass by simple majority.
  • Proxy Voting: Registered shareholder votes in person or via proxy form. Instructions for CDP shareholders and those holding through brokers are provided for timely submission of voting preferences.

Chairman’s Statement

No full Chairman’s statement is provided in the notice. The tone of the AGM agenda appears neutral and procedural, focused on governance matters, board continuity, and conservative financial management.

Potential Events and Business Risks

No mention is made of legal disputes, asset revaluation, fundraising, divestments, or exceptional earnings in the notice. The company appears to be operating under normal business conditions.

Conclusion and Investment Recommendations

Overall Financial Performance: The report suggests a stable and conservative financial approach, with interim dividends paid and remaining profits carried forward. The continuity in board and auditor appointments indicates no major governance disruptions. However, the absence of specific financial figures or performance metrics means that investors must refer to the full audited annual report for deeper analysis.

  • If you are currently holding the stock: Maintain your position. The company appears to prioritize stability and prudent management, with no negative surprises or governance issues disclosed. Await the full audited annual report for detailed financials prior to making any changes.
  • If you are not currently holding the stock: Consider monitoring Xtrackers and review the audited annual report when available. The current notice indicates stability but lacks detailed performance data to justify a new investment at this stage.

Disclaimer: This analysis is based solely on the contents of the AGM notice and does not constitute investment advice. Investors should review the full audited annual report and consult professional advisors before making any investment decisions.

OneApex Limited Reports Significant Profit Growth in FY2024 Financial Results

OneApex Limited: A Review of Financial Performance with 15.1...

Biolidics Limited Reports Q3 2024 Financial Results and Business Diversification Plans

Biolidics Limited Financial Analysis: Net Profit Decline of ...

   Ad